Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
8.08
-0.45 (-5.28%)
Oct 30, 2026, 11:27 AM EDT - Market open
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of $81.1 million as of October 30, 2026. It is the 26,132nd most valuable company in the world and the 4,203rd biggest in the United States. Its market cap has decreased by 17.83% in one year.
Market Cap
81.10M
Enterprise Value
81.11M
1-Year Change
-17.83%
Global Rank
Country Rank
#4,203 United States
Category
ChartMarket Cap Chart
Since October 16, 2014, Atara Biotherapeutics's market cap has decreased from $215.30M to $81.10M, a decrease of -62.33%. That is a compound annual growth rate of -7.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 81.10M | -37.80% |
| Dec 31, 2025 | 130.40M | 70.01% |
| Dec 31, 2024 | 76.70M | 46.65% |
| Dec 29, 2023 | 52.30M | -83.19% |
| Dec 30, 2022 | 311.20M | -77.67% |
| Dec 31, 2021 | 1.39B | -8.65% |
| Dec 31, 2020 | 1.53B | 71.04% |
| Dec 31, 2019 | 891.90M | -43.76% |
| Dec 31, 2018 | 1.59B | 186.35% |
| Dec 29, 2017 | 553.80M | 35.14% |
| Dec 30, 2016 | 409.80M | -45.80% |
| Dec 31, 2015 | 756.10M | 39.84% |
| Dec 31, 2014 | 540.70M | 151.14% |
| Oct 16, 2014 | 215.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genelux | 91.86M |
| Tenaya Therapeutics | 90.01M |
| ProMIS Neurosciences | 86.81M |
| Equillium | 86.23M |
| Rani Therapeutics Holdings | 84.93M |
| Rallybio | 84.60M |
| Conexeu Sciences | 83.21M |
| Cellectis | 82.89M |